80 FR 25295 - CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment; Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention

Federal Register Volume 80, Issue 85 (May 4, 2015)

[Federal Register Volume 80, Number 85 (Monday, May 4, 2015)]
[Notices]
[Pages 25295-25296]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-10306]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD 
Prevention and Treatment; Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC), in concurrence with and the Health Resources and 
Services Administration (HRSA), announces the following meeting of the 
aforementioned committee:
    Times and Dates:
    8:30 a.m.-5:30 p.m., May 20, 2015 (CDC/HRSA Advisory Committee on 
HIV, Viral Hepatitis and STD Prevention and Treatment (CHAC) meeting).
    9 a.m.-4:30 p.m., May 21, 2015 (CHAC and the Presidential Advisory 
Council on HIV/AIDS (PACHA) joint meeting).
    Place: The CHAC meeting will be held at CDC Corporate Square, 
Building 8, Conference Room 1-ABC, Corporate Boulevard, Atlanta, 
Georgia 30329; telephone (404) 639-8317. The meeting is also accessible 
by teleconference: Local (Atlanta, Georgia) number (404) 553-8912, 
Conference ID: 8317483; Toll-free number +1 (855) 348-8390, Conference 
ID: 8317483.
    The CHAC/PACHA joint meeting will be held at the W Hotel Atlanta 
Downtown, 45 Ivan Allen Jr. Boulevard, Salons 5 and 6, Atlanta, Georgia 
30308; telephone (404) 582-5800.
    Status: Both of the meetings are open to the public, limited only 
by the space available.
    Purpose: This Committee is charged with advising the Director, CDC 
and the Administrator, HRSA, regarding activities related to prevention 
and control of HIV/AIDS, Viral Hepatitis and other STDs, the support of 
health care services to persons living with HIV/AIDS, and education of 
health professionals and the public about HIV/AIDS, Viral Hepatitis and 
other STDs.
    Matters for Discussion: Agenda items include: (1) Role of STD 
clinics in Pre-Exposure Prophylaxis (PrEP); (2) Addressing Hepatitis C 
and HIV among people who inject drugs (PWID); (3) Update from viral 
hepatitis workgroup; and (4) considerations for the update of the 
National HIV/AIDS Strategy (joint meeting with PACHA).
    Agenda items are subject to change as priorities dictate.
    Contact Person For More Information: Margie Scott-Cseh, CDC, 
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, 
1600 Clifton Road, NE., Mailstop E-07, Atlanta, Georgia 30333; 
telephone (404) 639-8317.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register Notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and

[[Page 25296]]

Prevention and the Agency for Toxic Substances and Disease Registry.

Catherine Ramadei,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 2015-10306 Filed 5-1-15; 8:45 am]
 BILLING CODE 4163-18-P